MSeqDR Mitochondrial Disease Portal


 
*:HP: HPO terms, UMDF: 1= Disease, ND: NAMDC terms.
  Most Studied  CPEO, Complex I Deficiency, COXPD1, Leigh, LHON, MELAS, MERRF, Myopathy, SANDO
Disease Browser
Parent Node:
expand
Immunologic Deficiency Syndromes (D007153)
..Starting node
..expand
IMMUNODEFICIENCY 47 (OMIM:300972)

       Child Nodes:



 Sister Nodes: 
..expandActivated PI3K-delta Syndrome (C585640)
..expandAgammaglobulinemia (D000361) Child19
..expandAntibody Deficiency due to Defect in CD19 (C566275)
..expandAtaxia Telangiectasia (D001260) Child6
..expandAUTOINFLAMMATION, ANTIBODY DEFICIENCY, AND IMMUNE DYSREGULATION, PLCG2-ASSOCIATED (OMIM:614878)
..expandB-Cell Immunodeficiency, Distal Limb Anomalies, And Urogenital Malformations (C563745)
..expandC1q DEFICIENCY (OMIM:613652)
..expandC9 Deficiency (C565165)
..expandC9 Deficiency with Dermatomyositis (C565166)
..expandCartilage hair hypoplasia like syndrome (C535915)
..expandCartilage-hair hypoplasia (C535916)
..expandCd4+ Lymphocyte Deficiency (C566079)
..expandCD8 Deficiency, Familial (C563824)
..expandCombined Immunodeficiency with Autoimmunity and Spondylometaphyseal Dysplasia (C564307)
..expandCombined Inflammatory and Immunologic Defect (C565684)
..expandCommon Variable Immunodeficiency (D017074)
..expandCOMPLEMENT COMPONENT 2 DEFICIENCY (OMIM:217000)
..expandComplement Component 3 Deficiency, Autosomal Recessive (C565169)
..expandComplement Component 4, Partial Deficiency Of (C565168)
..expandComplement Component 4a Deficiency (C565167)
..expandCOMPLEMENT COMPONENT 4B DEFICIENCY (OMIM:614379)
..expandComplement component 5 deficiency (C537005)
..expandComplement Component 6 Deficiency (C567307)
..expandComplement Component 7 Deficiency (C566443)
..expandCOMPLEMENT COMPONENT C1r/C1s DEFICIENCY (OMIM:216950)
..expandComplement Component C1s Deficiency (C565170)
..expandCOMPLEMENT FACTOR B DEFICIENCY (OMIM:615561)
..expandComplement Factor D Deficiency (C565027)
..expandDavenport Donlan syndrome (C535988)
..expandDeltaretrovirus Infections (D006800) Child4
..expandDiarrhea, Glucose-Stimulated Secretory, with Common Variable Immunodeficiency (C565099)
..expandDysgammaglobulinemia (D004406) Child11
..expandEctodermal Dysplasia, Anhidrotic, with Immunodeficiency, Osteopetrosis, and Lymphedema (C564538)
..expandEctodermal Dysplasia, Anhidrotic, With T-Cell Immunodeficiency, Autosomal Dominant (C567411)
..expandEctodermal dysplasia, hypohidrotic, with immune deficiency (C536181)
..expandEndotoxin Hyporesponsiveness (C566417)
..expandEnteropathy, Familial, with Villous Edema and Immunoglobulin G2 Deficiency (C563949)
..expandERYTHRODERMA, CONGENITAL, WITH PALMOPLANTAR KERATODERMA, HYPOTRICHOSIS, AND HYPER-IgE (OMIM:615508)
..expandFACIAL DYSMORPHISM, IMMUNODEFICIENCY, LIVEDO, AND SHORT STATURE (OMIM:615139)
..expandFanconi like syndrome (C536855)
..expandFICOLIN 3 DEFICIENCY (OMIM:613860)
..expandGriscelli syndrome type 2 (C537302)
..expandHepatic venoocclusive disease with immunodeficiency (C537257)
..expandHIV Infections (D015658) Child12
..expandHypoglobulinemia and Absent B Cells (C565765)
..expandImmune Deficiency Disease (C565469)
..expandImmune Deficiency, Familial Variable (C564136)
..expandIMMUNODEFICIENCY 11 (OMIM:615206)
..expandIMMUNODEFICIENCY 12 (OMIM:615468)
..expandIMMUNODEFICIENCY 14 (OMIM:615513)
..expandIMMUNODEFICIENCY 15B (OMIM:615592)
..expandIMMUNODEFICIENCY 16 (OMIM:615593)
..expandIMMUNODEFICIENCY 17 (OMIM:615607)
..expandIMMUNODEFICIENCY 18 (OMIM:615615)
..expandIMMUNODEFICIENCY 19 (OMIM:615617)
..expandIMMUNODEFICIENCY 20 (OMIM:615707)
..expandIMMUNODEFICIENCY 21 (OMIM:614172)
..expandIMMUNODEFICIENCY 22 (OMIM:615758)
..expandIMMUNODEFICIENCY 23 (OMIM:615816)
..expandIMMUNODEFICIENCY 24 (OMIM:615897)
..expandIMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES (OMIM:615966)
..expandIMMUNODEFICIENCY 27B (OMIM:615978)
..expandIMMUNODEFICIENCY 28 (OMIM:614889)
..expandIMMUNODEFICIENCY 29 (OMIM:614890)
..expandIMMUNODEFICIENCY 30 (OMIM:614891)
..expandIMMUNODEFICIENCY 31A (OMIM:614892)
..expandIMMUNODEFICIENCY 31B (OMIM:613796)
..expandIMMUNODEFICIENCY 31C (OMIM:614162)
..expandIMMUNODEFICIENCY 32A (OMIM:614893)
..expandIMMUNODEFICIENCY 32B (OMIM:226990)
..expandIMMUNODEFICIENCY 36 (OMIM:616005)
..expandIMMUNODEFICIENCY 37 (OMIM:616098)
..expandIMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION (OMIM:616126)
..expandIMMUNODEFICIENCY 39 (OMIM:616345)
..expandIMMUNODEFICIENCY 40 (OMIM:616433)
..expandIMMUNODEFICIENCY 42 (OMIM:616622)
..expandIMMUNODEFICIENCY 44 (OMIM:616636)
..expandIMMUNODEFICIENCY 45 (OMIM:616669)
..expandIMMUNODEFICIENCY 46 (OMIM:616740)
..expandIMMUNODEFICIENCY 47 (OMIM:300972)
..expandIMMUNODEFICIENCY 48 (OMIM:269840)
..expandIMMUNODEFICIENCY 49 (OMIM:617237)
..expandIMMUNODEFICIENCY 50 (OMIM:300988)
..expandIMMUNODEFICIENCY 51 (OMIM:613953)
..expandIMMUNODEFICIENCY 54 (OMIM:609981)
..expandIMMUNODEFICIENCY 56 (OMIM:615207)
..expandIMMUNODEFICIENCY 8 (OMIM:615401)
..expandImmunodeficiency due to Defect in CD3-Epsilon (C566082)
..expandImmunodeficiency due to Defect in CD3-Gamma (C566083)
..expandImmunodeficiency due to Defect in CD3-Zeta (C565712)
..expandImmunodeficiency due to Defect in MAPBP-Interacting Protein (C563663)
..expandImmunodeficiency syndrome, variable (C537362) Child1
..expandImmunodeficiency with Defective Leukocyte and Lymphocyte Function and with Response to Histamine-1 Antagonist (C564135)
..expandImmunodeficiency without anhidrotic ectodermal dysplasia (C536289)
..expandImmunodeficiency, Gonadal Dysgenesis, And Pulmonary Fibrosis (C567457)
..expandImmunodeficiency, Hypogammaglobulinemia, and Reduced B Cells (C567200)
..expandImmunodeficiency, Partial Combined, with Absence of HLA Determinants and Beta-2-Microglobulin from Lymphocytes (C565468)
..expandImmunodeficiency, X-Linked, with Deficiency of 115,000 Dalton Surface Glycoprotein (C564120)
..expandIMMUNOGLOBULIN KAPPA LIGHT CHAIN DEFICIENCY (OMIM:614102)
..expandInosine Phosphorylase Deficiency, Immune Defect Due To (C565465)
..expandInterleukin 2 Receptor, Alpha, Deficiency of (C565232)
..expandInvasive Pneumococcal Disease, Recurrent Isolated, 1 (C563662)
..expandInvasive Pneumococcal Disease, Recurrent Isolated, 2 (C564468)
..expandIRAK4 Deficiency (C564352)
..expandKappa-Chain Deficiency (C564131)
..expandKotzot-Richter syndrome (C537025)
..expandLeukocyte-Adhesion Deficiency Syndrome (D018370) Child2
..expandLichtenstein syndrome (C535894)
..expandLIG4 Syndrome (C564694)
..expandLUNG DISEASE, IMMUNODEFICIENCY, AND CHROMOSOME BREAKAGE SYNDROME (OMIM:617241)
..expandLymphoblastic Transformation, Intrinsic Defect in (C565431)
..expandLymphoid System Deterioration, Progressive (C565430)
..expandLymphokine Deficiency (C565428)
..expandLymphopenia (D008231) Child5
..expandLymphopenic Hypergammaglobulinemia, Antibody Deficiency, Autoimmune Hemolytic Anemia, and Glomerulonephritis (C565427)
..expandMASP2 Deficiency (C565360)
..expandMYD88 Deficiency (C567379)
..expandMyelodysplasia, Immunodeficiency, Facial Dysmorphism, Short Stature, and Psychomotor Delay (C563345)
..expandNatural Killer Cell Deficiency, Familial Isolated (C566492)
..expandNEMO mutation with immunodeficiency (C538399)
..expandNeutrophil Immunodeficiency Syndrome (C564275)
..expandPhagocyte Bactericidal Dysfunction (D010585) Child14
..expandProperdin Deficiency, Type II (C564075)
..expandProperdin Deficiency, Type III (C564076)
..expandRiddle Syndrome (C567453)
..expandRoifman syndrome (C535866)
..expandRoifman-Chitayat Syndrome (C567641)
..expandSchimke immunoosseous dysplasia (C536629)
..expandSevere Combined Immunodeficiency (D016511) Child22  LSDB C:1
..expandSevere Combined Immunodeficiency, Autosomal Recessive, T Cell-Negative, B Cell-Negative, NK Cell-Positive (C563311)
..expandSplenic Hypoplasia (C563028)
..expandT cell immunodeficiency primary (C536780)
..expandT-CELL IMMUNODEFICIENCY, RECURRENT INFECTIONS, AND AUTOIMMUNITY WITH OR WITHOUT CARDIAC MALFORMATIONS (OMIM:614868)
..expandT-Cell OKT4 Deficiency (C566080)
..expandT-CELL RECEPTOR-ALPHA/BETA DEFICIENCY (OMIM:615387)
..expandThumb Agenesis, Short Stature, And Immunodeficiency (C564770)
..expandThymic aplasia (C536288)
..expandTuftsin Deficiency (C562872)
..expandWHIM syndrome (C536697)
   

Human Disease MESH is developed by UMLS.
Further data from MedGen, OMIM,ClinVar, CTD
Term ID:6282
Name:IMMUNODEFICIENCY 47
Definition:
Alternative IDs:
ParentIDs:MESH:D007153
TreeNumbers:C20.673/300972
Synonyms:IMD47 |IMMUNODEFICIENCY AND HEPATOPATHY WITH OR WITHOUT NEUROLOGIC FEATURES
Slim Mappings:Immune system disease
Reference: MedGen: 300972
MeSH: 300972
OMIM: 300972;
MSeqDR LSDB:  
Genes:
Phenotypes
1 HP:0001419X-linked recessive inheritance
2 HP:0001394Cirrhosis
NAMDC:  Cirrhosis
3 HP:0004313Decreased antibody level in blood
4 HP:0002910Elevated hepatic transaminases
5 HP:0001397Hepatic steatosis
NAMDC:  Hepatopathy with steatosis or oncocytic changes by liver biopsy
6 HP:0002240Hepatomegaly
7 HP:0000540Hypermetropia
8 HP:0001249Intellectual disabilityHP:0040283
9 HP:0001882Leukopenia
10 HP:0006579Prolonged neonatal jaundice
11 HP:0002718Recurrent bacterial infections
12 HP:0001250Seizures
NAMDC:  Seizures
HP:0040283
13 HP:0000407Sensorineural hearing impairment
NAMDC:  Sensorineural hearing loss
14 HP:0001744Splenomegaly
15 HP:0003828Variable expressivity
Disease Causing ClinVar Variants
Variation_NameGeneIDGeneSymbolClinicalSignificancedbSNPRCVaccessionTestedInGTRPhenotypeIDsChromosomeStartStopHGVS_cHGVS_pHGVS_gOtherIDsDisease_ClinVar
NM_001183.6(ATP6AP1):c.216G>A (p.Leu72=)537ATP6AP1Conflicting interpretations of pathogenicity-1RCV002590148|RCV003146587; NMedGen:CN517202|MONDO:MONDO:0010504,MedGen:C4310819,OMIM:300972X153657448153657448-
NM_001183.6(ATP6AP1):c.220C>G (p.Leu74Val)537ATP6AP1Conflicting interpretations of pathogenicity-1RCV003312786|RCV003330115; NMedGen:C3661900|MONDO:MONDO:0010504,MedGen:C4310819,OMIM:300972X153657452153657452-
NM_001183.6(ATP6AP1):c.221T>C (p.Leu74Pro)537ATP6AP1Pathogenic2068680774RCV001171364; NMONDO:MONDO:0010504,MedGen:C4310819,OMIM:300972X153657453153657453X:g.153657453T>COMIM:300197.0006
NM_001183.6(ATP6AP1):c.230_232del (p.Tyr77del)537ATP6AP1Likely pathogenic2148221946RCV002248303; NMONDO:MONDO:0010504,MedGen:C4310819,OMIM:300972X153657460153657462153657459-
NM_001183.6(ATP6AP1):c.289-135=537ATP6AP1Benign11156577RCV000843501|RCV001553938; NMedGen:C3661900|MONDO:MONDO:0010504,MedGen:C4310819,OMIM:300972X153660041153660041X:g.153660041C>T-
NM_001183.6(ATP6AP1):c.301G>A (p.Asp101Asn)537ATP6AP1Uncertain significance-1RCV003143651; NMONDO:MONDO:0010504,MedGen:C4310819,OMIM:300972X153660188153660188NC_000023.10:g.153660188G>A-
NM_001183.6(ATP6AP1):c.385T>C (p.Ser129Pro)537ATP6AP1Uncertain significance-1RCV003152911; NMONDO:MONDO:0010504,MedGen:C4310819,OMIM:300972X153660633153660633-
NM_001183.6(ATP6AP1):c.431T>C (p.Leu144Pro)537ATP6AP1Pathogenic878853276RCV000225250; NMONDO:MONDO:0010504,MedGen:C4310819,OMIM:300972X153660679153660679X:g.153660679T>CClinGen:CA10581575,UniProtKB:Q15904#VAR_077021,OMIM:300197.0002C3151226 613860 Immunodeficiency due to ficolin 3 deficiency;
NM_001183.6(ATP6AP1):c.473A>T (p.His158Leu)537ATP6AP1Uncertain significance-1RCV003340895; NMONDO:MONDO:0010504,MedGen:C4310819,OMIM:300972X153660721153660721-
NM_001183.6(ATP6AP1):c.515G>C (p.Ser172Thr)537ATP6AP1Uncertain significance-1RCV003143652; NMONDO:MONDO:0010504,MedGen:C4310819,OMIM:300972X153660763153660763NC_000023.10:g.153660763G>C-
NM_001183.6(ATP6AP1):c.530T>C (p.Leu177Pro)537ATP6AP1Likely pathogenic-1RCV003149154; NMONDO:MONDO:0010504,MedGen:C4310819,OMIM:300972X153660778153660778-
NM_001183.6(ATP6AP1):c.542T>G (p.Leu181Arg)537ATP6AP1Conflicting interpretations of pathogenicity1557196978RCV000590996|RCV001857199; NMONDO:MONDO:0010504,MedGen:C4310819,OMIM:300972|MedGen:CN517202X153660790153660790X:g.153660790T>GClinGen:CA415190062,OMIM:300197.0005C4310819 300972 Immunodeficiency 47;
NM_001183.6(ATP6AP1):c.560C>T (p.Ser187Phe)537ATP6AP1Uncertain significance-1RCV003329096; NMONDO:MONDO:0010504,MedGen:C4310819,OMIM:300972X153661279153661279-
NM_001183.6(ATP6AP1):c.649T>A (p.Tyr217Asn)537ATP6AP1Pathogenic2068705545RCV001250487; NMONDO:MONDO:0010504,MedGen:C4310819,OMIM:300972X153662031153662031X:g.153662031T>AOMIM:300197.0008
NM_001183.6(ATP6AP1):c.674G>A (p.Arg225His)537ATP6AP1Uncertain significance782349780RCV001195771; NMONDO:MONDO:0010504,MedGen:C4310819,OMIM:300972X153662056153662056X:g.153662056G>A-
NM_001183.6(ATP6AP1):c.932T>A (p.Leu311Gln)537ATP6AP1Conflicting interpretations of pathogenicity1603384499RCV000991196|RCV001171365; N|MONDO:MONDO:0010504,MedGen:C4310819,OMIM:300972X153663493153663493X:g.153663493T>AOMIM:300197.0007
NM_001183.6(ATP6AP1):c.938A>G (p.Tyr313Cys)537ATP6AP1Pathogenic878853278RCV000225189|RCV003238745; NMONDO:MONDO:0010504,MedGen:C4310819,OMIM:300972|MedGen:CN517202X153663499153663499X:g.153663499A>GClinGen:CA10581577,UniProtKB:Q15904#VAR_077022,OMIM:300197.0004C3151226 613860 Immunodeficiency due to ficolin 3 deficiency;
NM_001183.6(ATP6AP1):c.971+10G>A537ATP6AP1Conflicting interpretations of pathogenicity-1RCV002843740|RCV003225772; NMedGen:C3661900|MONDO:MONDO:0010504,MedGen:C4310819,OMIM:300972X153663542153663542NC_000023.10:g.153663542G>A-
NM_001183.6(ATP6AP1):c.1031G>A (p.Arg344His)537ATP6AP1Uncertain significance781936333RCV001823571|RCV002542733|RCV002545194; NMONDO:MONDO:0010504,MedGen:C4310819,OMIM:300972|MeSH:D030342,MedGen:C0950123|MedGen:C3661900X153663679153663679153663679-
NM_001183.6(ATP6AP1):c.1036G>A (p.Glu346Lys)537ATP6AP1Pathogenic/Likely pathogenic878853277RCV000225332|RCV001560673; NMONDO:MONDO:0010504,MedGen:C4310819,OMIM:300972|MedGen:CN517202X153663684153663684NC_000023.10:g.153663684G>AClinGen:CA10581576,UniProtKB:Q15904#VAR_077023,OMIM:300197.0003C3151226 613860 Immunodeficiency due to ficolin 3 deficiency;
NM_001183.6(ATP6AP1):c.1284G>A (p.Met428Ile)537ATP6AP1Pathogenic878853275RCV000225137; NMONDO:MONDO:0010504,MedGen:C4310819,OMIM:300972X153664108153664108X:g.153664108G>AUniProtKB:Q15904#VAR_077024,OMIM:300197.0001,ClinGen:CA10581574C3151226 613860 Immunodeficiency due to ficolin 3 deficiency;
MSeqDR Portal